Your browser doesn't support javascript.
loading
Proteomic Analysis Reveals a PLK1-Dependent G2/M Degradation Program and Links PKA-AKAP2 to Cell Cycle Control.
Mouery, Ryan D; Hsu, Carolyn; Bonacci, Thomas; Bolhuis, Derek L; Wang, Xianxi; Mills, Christine A; Toomer, E Drew; Canterbury, Owen G; Robertson, Kevin C; Branigan, Timothy B; Brown, Nicholas G; Herring, Laura E; Emanuele, Michael J.
Afiliação
  • Mouery RD; Curriculum in Genetics and Molecular Biology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Hsu C; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Bonacci T; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Bolhuis DL; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Wang X; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Mills CA; Department of Biochemistry and Biophysics. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Toomer ED; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Canterbury OG; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Robertson KC; UNC Proteomics Core Facility, Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Branigan TB; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Brown NG; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Herring LE; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
  • Emanuele MJ; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.
bioRxiv ; 2023 Oct 12.
Article em En | MEDLINE | ID: mdl-37873169
ABSTRACT
Targeted protein degradation by the ubiquitin-proteasome system is an essential mechanism regulating cellular division. The kinase PLK1 coordinates protein degradation at the G2/M phase of the cell cycle by promoting the binding of substrates to the E3 ubiquitin ligase SCFßTrCP. However, the magnitude to which PLK1 shapes the mitotic proteome has not been characterized. Combining deep, quantitative proteomics with pharmacologic PLK1 inhibition (PLK1i), we identified more than 200 proteins whose abundances were increased by PLK1i at G2/M. We validate many new PLK1-regulated proteins, including several substrates of the cell cycle E3 SCFCyclin F, demonstrating that PLK1 promotes proteolysis through at least two distinct SCF-family E3 ligases. Further, we found that the protein kinase A anchoring protein AKAP2 is cell cycle regulated and that its mitotic degradation is dependent on the PLK1/ßTrCP-signaling axis. Interactome analysis revealed that the strongest interactors of AKAP2 function in signaling networks regulating proliferation, including MAPK, AKT, and Hippo. Altogether, our data demonstrate that PLK1 coordinates a widespread program of protein breakdown at G2/M. We propose that dynamic proteolytic changes mediated by PLK1 integrate proliferative signals with the core cell cycle machinery during cell division. This has potential implications in malignancies where PLK1 is aberrantly regulated.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article